LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Book: Urinary tract stone disease

    Rao, Nagaraja P. / Preminger, Glenn M. / Kavanagh, John P.

    2011  

    Author's details P. Nagaraja P. Rao ; Glenn M. Preminger ; John P. Kavanagh
    Keywords Urinary organs/Calculi
    Subject code 616.622
    Language English
    Size XIX, 720 S. : Ill., graph. Darst., 26cm
    Publisher Springer
    Publishing place London
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT016733952
    ISBN 978-1-84800-362-0 ; 1-8480-0361-7 ; 1-84800-362-5 ; 978-1-8480-0361-3
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book: Urological tests in clinical practice

    Rao, Nagaraja P. / Srirangam, Shalom J. / Preminger, Glenn M.

    2007  

    Author's details Nagaraja P. Rao ; Shalom J. Srirangam ; Glenn M. Preminger
    Language English
    Size X, 291 S. : Ill., graph. Darst.
    Publisher Springer
    Publishing place London
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT014940559
    ISBN 1-84628-390-6 ; 978-1-84628-390-1
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Article: Post-COVID-19 Cholestasis: A Case Series and Review of Literature.

    Kulkarni, Anand V / Khelgi, Amit / Sekaran, Anuradha / Reddy, Raghuram / Sharma, Mithun / Tirumalle, Sowmya / Gora, Baqar A / Somireddy, Arjun / Reddy, Jignesh / Menon, Balachandran / Reddy, Duvvur N / Rao, Nagaraja P

    Journal of clinical and experimental hepatology

    2022  Volume 12, Issue 6, Page(s) 1580–1590

    Abstract: Background: Coronavirus disease-2019 (COVID-19) cholangiopathy is a recently known entity. There are very few reports of liver transplantation (LT) for COVID-19-induced cholangiopathy. It is well known that vaccines can prevent severe disease and ... ...

    Abstract Background: Coronavirus disease-2019 (COVID-19) cholangiopathy is a recently known entity. There are very few reports of liver transplantation (LT) for COVID-19-induced cholangiopathy. It is well known that vaccines can prevent severe disease and improve outcomes. However, there are no reports on the impact of COVID-19 vaccines on cholestasis. Therefore, we aimed to compare the course and outcome of patients who developed cholestasis following COVID-19 infection among vaccinated and unvaccinated individuals.
    Results: Eight unvaccinated and seven vaccinated individuals developed cholestasis following COVID-19 infection. Baseline demographics, presentation, severity, and management of COVID-19 were similar in both groups. However, patients in the unvaccinated group had a protracted course. The peak ALP was 312 (239-517) U/L in the vaccinated group and 571.5 (368-1058) U/L in the unvaccinated group (
    Conclusion: Post-COVID-19 cholestasis is associated with high morbidity and mortality, meriting early identification and appropriate management. Vaccination can modify the course of severe COVID-19 infection and improve outcomes.
    Language English
    Publishing date 2022-06-11
    Publishing country India
    Document type Case Reports
    ISSN 0973-6883
    ISSN 0973-6883
    DOI 10.1016/j.jceh.2022.06.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Prophylactic Perioperative Terlipressin Therapy for Preventing Acute Kidney Injury in Living Donor Liver Transplant Recipients: A Systematic Review and Meta-Analysis.

    Kulkarni, Anand V / Kumar, Karan / Candia, Roberto / Arab, Juan P / Tevethia, Harsh V / Premkumar, Madhumita / Sharma, Mithun / Menon, Balachandandran / Rao, Guduru V / Reddy, Nageshwar D / Rao, Nagaraja P

    Journal of clinical and experimental hepatology

    2021  Volume 12, Issue 2, Page(s) 417–427

    Abstract: Background: Acute kidney injury (AKI) is common in the perioperative transplant period and is associated with poor outcomes. Few studies reported a reduction in AKI incidence with terlipressin therapy by counteracting the hemodynamic alterations ... ...

    Abstract Background: Acute kidney injury (AKI) is common in the perioperative transplant period and is associated with poor outcomes. Few studies reported a reduction in AKI incidence with terlipressin therapy by counteracting the hemodynamic alterations occurring during liver transplantation. However, the effect of terlipressin on posttransplant outcomes has not been systematically reviewed.
    Methods: A comprehensive search of electronic databases was performed. Studies reporting the use of terlipressin in the perioperative period of living donor liver transplantation were included. We expressed the dichotomous outcomes as risk ratio (RR, 95% confidence interval [CI]) using the random effects model. The primary aim was to assess the posttransplant risk of AKI. The secondary aims were to assess the need for renal replacement therapy (RRT), vasopressors, effect on hemodynamics, blood loss during surgery, hospital and intensive care unit (ICU) stay, and in-hospital mortality.
    Results: A total of nine studies reporting 711 patients (309 patients in the terlipressin group and 402 in the control group) were included for analysis. Terlipressin was administered for a mean duration of 53.44 ± 28.61 h postsurgery. The risk of AKI was lower with terlipressin (0.6 [95% CI, 0.44-0.8];
    Conclusions: Perioperative terlipressin therapy has no clinically relevant benefit.
    Language English
    Publishing date 2021-06-25
    Publishing country India
    Document type Journal Article
    ISSN 0973-6883
    ISSN 0973-6883
    DOI 10.1016/j.jceh.2021.06.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Fractional Excretion of Sodium and Urea in Differentiating Acute Kidney Injury Phenotypes in Decompensated Cirrhosis.

    Gowda, Yashavanth H S / Jagtap, Nitin / Karyampudi, Arun / Rao, Nagaraja P / Deepika, Gujjarapudi / Sharma, Mithun / Gupta, Rajesh / Tandan, Manu / Ramchandani, Mohan / John, Priyadarshini / Kulkarni, Anand / Kumar, Pramod / Bhaware, Bhushan / Turpati, Mohan V / Reddy, D Nageshwar

    Journal of clinical and experimental hepatology

    2021  Volume 12, Issue 3, Page(s) 899–907

    Abstract: Background: Prerenal acute kidney injury (prerenal AKI), hepatorenal syndrome (HRS-AKI), and acute tubular necrosis (ATN-AKI) are the various phenotypes of acute kidney injury, which are described in decompensated cirrhosis. It has therapeutic and ... ...

    Abstract Background: Prerenal acute kidney injury (prerenal AKI), hepatorenal syndrome (HRS-AKI), and acute tubular necrosis (ATN-AKI) are the various phenotypes of acute kidney injury, which are described in decompensated cirrhosis. It has therapeutic and prognostic implications. We aimed to evaluate the diagnostic utility of fractional excretion of sodium and urea (FENa and FEUrea) for differentiating AKI phenotypes.
    Methods: A prospective analysis was performed in 200 patients with decompensated cirrhosis with AKI to derive receiver operating curve, optimal cut-off, sensitivity, and specificity. These findings were validated in an independent cohort (n = 50) to differentiate ATN-AKI, HRS-AKI, and prerenal AKI.
    Results: The incidence of prerenal AKI, HRS-AKI, and ATN-AKI were 37.5%, 34%, and 28.5% in the derivation cohort and 28%, 38%, and 34% in the validation cohort respectively. The median FENa was significantly different in various phenotypes of AKI in the derivation and validation cohort (
    Conclusion: Among cirrhotics FENa at admission is a simple, commonly available clinical tool that can be used to differentiate structural AKI from prerenal AKI and HRS-AKI. The newly derived lowered cut-off value of FENa makes the diagnosis of ATN-AKI easier, faster and thus obviates the need for extensive workup in a significant proportion of patients. FENa appears better than FEUrea in decompensated cirrhosis with AKI.
    Language English
    Publishing date 2021-09-28
    Publishing country India
    Document type Journal Article
    ISSN 0973-6883
    ISSN 0973-6883
    DOI 10.1016/j.jceh.2021.09.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Book ; Online: Urinary Tract Stone Disease

    Rao, Nagaraja P / Kavanagh, John P / Preminger, Glenn M

    2011  

    Abstract: This book covers the entire subject of urinary tract stone disease from basic sciences to medical and surgical treatment of stones with the aim to cover the entire spectrum of this disease. The surgical management of stone disease has changed ... ...

    Author's details edited by Nagaraja P. Rao, Glenn M. Preminger, John P. Kavanagh
    Abstract This book covers the entire subject of urinary tract stone disease from basic sciences to medical and surgical treatment of stones with the aim to cover the entire spectrum of this disease. The surgical management of stone disease has changed considerably in the last five years and our understanding of mechanism of stone disease has improved with some old concepts discarded and newer theories gaining ground. More than fifty internationally recognised experts have contributed (with 50% from the US and 50% from rest of the world, including Europe). The book is extensively illustrated with photographs, x-rays and line diagrams. This exhaustive and complex reference work will be particularly valuable to urologists, nephrologists and non-medical scientists.
    Keywords Medicine ; Nephrology ; Urology ; Medizin / Gesundheit # Urologie
    Language English
    Size Online-Ressource, v.: digital
    Publisher Springer-Verlag London Limited
    Publishing place London
    Document type Book ; Online
    Note Includes bibliographical references and index
    ISBN 9781848003613 ; 9781848003620 ; 1848003617 ; 1848003625
    DOI 10.1007/978-1-84800-362-0
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

To top